About: The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain. Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain. (en) The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain. (nl)
skos:prefLabel	The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain. (en) The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain. (nl)
name	The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain. (en) The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain. (nl)
title	wds:Q65391075-00947E07-033B-44AB-A1C2-9ADF755626DC
title	Safety and Efficacy of Buprenorphine TDS (Transdermal Delivery System) 5, 10 and 20 Applied Every 7 Days for Sixty Days vs. 5 mg Oxycodone/325 mg Acetaminophen Tablets q6h Prn vs. Placebo in Patients With Chronic Low Back Pain (en)
instance of	wds:Q65391075-819F87C2-51F0-42DD-940E-52AFECFAF13F
instance of	clinical trial
start time	wds:Q65391075-A413A561-F3AC-4805-9249-80A8AF81502C
start time	1997-04-01 00:00:00Z (xsd:dateTime)
country	wds:Q65391075-22ED1A79-01BA-4FDB-83BF-DA29B846816C
country	United States of America
research site	wds:Q65391075-7F2A6E14-59BE-4B2E-9844-AAC2378C96E8
research site	Metroplex Clinical Research Center
research intervention	wds:Q65391075-E182299E-BFFC-4DDC-8D58-ABDFD814FADF
research intervention	buprenorphine
minimum age	wds:Q65391075-31F005DA-4D4C-4EB7-9772-1D19A9FAE6D3
minimum age	18 (xsd:decimal)
number of participants	wds:Q65391075-71EE5A2F-288C-4891-A324-9E32CE85C746
number of participants	225 (xsd:decimal)
study type	wds:Q65391075-1562C75C-F240-46AF-AB74-0E5569CAFE33
study type	interventional study
ClinicalTrials.gov ID	wds:Q65391075-86828AD2-BF10-4D10-A589-BC6E112D4EF5
ClinicalTrials.gov ID	NCT00315874
clinical trial phase	wds:Q65391075-9CD8A47B-5438-4B10-A16C-9B36C1349CE0
clinical trial phase	phase III clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q65391075

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software